Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Immune-Onc Therapeutics
company
About
Immune-Onc Therapeutics is a newly established biopharmaceutical company that develops therapeutic antibodies for cancer treatment.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $25M
- Industries
- Biopharma,Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2016
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Immune-Onc Therapeutics is a newly established bio-pharmaceutical company that focuses on developing innovative therapeutic antibodies for cancer treatment. The company applies the latest scientific insights and expertise in drug development to advance novel immuno-oncology products and bring new treatment options to cancer patients.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$32M
Immune-Onc Therapeutics has raised a total of
$32M
in funding over 2 rounds. Their latest funding was raised on
Jan 5, 2023 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 5, 2023 | Series B | $25M | 1 | — | — | Detail |
| Sep 1, 2016 | Series A | $7M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Immune-Onc Therapeutics is funded by 2 investors.
Qianzhan Investment Management
and Fame Mount Limited
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
|
|
— | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
